Reactivated LIN28A or LIN28B expression almost invariably correlates with poor prognosis in many tumors, including acute myeloid leukemia [36], brain cancers [37,38], and NB [15,16,17]. This evidence concerns the gene LIN28A and acute myeloid leukemia.